A UK Delphi consensus study on the definition and management of advanced cutaneous squamous cell carcinoma
Open Access
- 14 September 2026
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 22 (22) , 2693-2708
Abstract
1. Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer in the United Kingdom (UK), and its incidence continues to rise each year [1,2]. When treated early, cSCC has a goo...Keywords
Funding Information
- Regeneron Pharmaceuticals
- Triducive Partners Limited
This publication has 54 references indexed in Scilit:
- The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for ChangeInternational Journal of Cancer, 2026
- Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint InhibitorsJAMA Oncology, 2025
- The impact of surgical margins in managing regional metastases in cutaneous squamous cell carcinoma of the head and neckThe Laryngoscope, 2025
- Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomasJournal of Cancer Research and Clinical Oncology, 2024
- Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell CarcinomaJAMA Dermatology, 2023
- The Current Treatment Landscape of Cutaneous Squamous Cell CarcinomaAmerican Journal of Clinical Dermatology, 2022
- Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell CarcinomaJAMA Dermatology, 2022
- Cutaneous squamous cell carcinoma staging may influence management in users: A survey studyCancer Medicine, 2021
- Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node MetastasisJAMA Otolaryngology–Head & Neck Surgery, 2019
- Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific DeathJAMA Dermatology, 2016